DZ2389A1 - New farnesyl transferase inhibitors their preparation of the pharmaceutical compositions containing them and their use for the preparation of medicaments - Google Patents
New farnesyl transferase inhibitors their preparation of the pharmaceutical compositions containing them and their use for the preparation of medicamentsInfo
- Publication number
- DZ2389A1 DZ2389A1 DZ970239A DZ970239A DZ2389A1 DZ 2389 A1 DZ2389 A1 DZ 2389A1 DZ 970239 A DZ970239 A DZ 970239A DZ 970239 A DZ970239 A DZ 970239A DZ 2389 A1 DZ2389 A1 DZ 2389A1
- Authority
- DZ
- Algeria
- Prior art keywords
- preparation
- medicaments
- pharmaceutical compositions
- compositions containing
- transferase inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/58—[b]- or [c]-condensed
- C07D209/72—4,7-Endo-alkylene-iso-indoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Epoxy Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9616206A FR2757855B1 (en) | 1996-12-30 | 1996-12-30 | NOVEL FARNESYL TRANSFERASE INHIBITORS, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DZ2389A1 true DZ2389A1 (en) | 2002-12-28 |
Family
ID=9499293
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DZ970239A DZ2389A1 (en) | 1996-12-30 | 1997-12-27 | New farnesyl transferase inhibitors their preparation of the pharmaceutical compositions containing them and their use for the preparation of medicaments |
Country Status (32)
| Country | Link |
|---|---|
| EP (1) | EP0948483B1 (en) |
| JP (1) | JP2001509147A (en) |
| KR (1) | KR20000062391A (en) |
| AR (1) | AR008950A1 (en) |
| AT (1) | ATE214367T1 (en) |
| AU (1) | AU741921B2 (en) |
| BR (1) | BR9714498A (en) |
| CA (1) | CA2275943A1 (en) |
| CO (1) | CO4920252A1 (en) |
| CZ (1) | CZ233599A3 (en) |
| DE (1) | DE69711081T2 (en) |
| DK (1) | DK0948483T3 (en) |
| DZ (1) | DZ2389A1 (en) |
| EA (1) | EA002114B1 (en) |
| ES (1) | ES2172033T3 (en) |
| FR (1) | FR2757855B1 (en) |
| HU (1) | HUP0001747A3 (en) |
| ID (1) | ID22922A (en) |
| IL (1) | IL130453A0 (en) |
| MA (1) | MA26460A1 (en) |
| NO (1) | NO993225L (en) |
| NZ (1) | NZ336042A (en) |
| PE (1) | PE28199A1 (en) |
| PL (1) | PL334345A1 (en) |
| PT (1) | PT948483E (en) |
| SK (1) | SK88399A3 (en) |
| TN (1) | TNSN97214A1 (en) |
| TR (1) | TR199901502T2 (en) |
| UY (1) | UY24832A1 (en) |
| WO (1) | WO1998029390A1 (en) |
| YU (1) | YU30299A (en) |
| ZA (1) | ZA9711734B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2787327B1 (en) * | 1998-12-21 | 2003-01-17 | Aventis Pharma Sa | COMPOSITIONS CONTAINING FARNESYL TRANSFERASE INHIBITORS |
| FR2796640A1 (en) * | 1999-07-22 | 2001-01-26 | Aventis Pharma Sa | New 3,9-ethano-2,3,3a,4,9,9a-hexahydro-1H-benzo (f) isoindole derivatives, are farnesyl transferase inhibitors useful for treating hyperproliferative disorders, e.g. psoriasis, restenosis or especially cancer |
| FR2796641B1 (en) * | 1999-07-22 | 2001-09-21 | Aventis Pharma Sa | NOVEL PROCESS FOR THE PREPARATION OF BENZOPERHYDROISOINDOLE COMPOUNDS |
| FR2845994B1 (en) * | 2002-10-18 | 2006-05-19 | Servier Lab | NOVEL SUBSTITUTED BENZO [E] [1,4] OXAZINO [3,2-G] ISOINDOLE DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
| WO2005089504A2 (en) * | 2004-03-18 | 2005-09-29 | The Brigham And Women's Hospital, Inc. | Methods for the treatment of synucleinopathies |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0730605A1 (en) * | 1993-11-05 | 1996-09-11 | Warner-Lambert Company | Substituted di- and tripeptide inhibitors of protein:farnesyl transferase |
| FR2736641B1 (en) * | 1995-07-10 | 1997-08-22 | Rhone Poulenc Rorer Sa | NOVEL FARNESYL TRANSFERASE INHIBITORS, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
-
1996
- 1996-12-30 FR FR9616206A patent/FR2757855B1/en not_active Expired - Fee Related
-
1997
- 1997-12-03 PE PE1997001089A patent/PE28199A1/en not_active Application Discontinuation
- 1997-12-23 EP EP97953000A patent/EP0948483B1/en not_active Expired - Lifetime
- 1997-12-23 DK DK97953000T patent/DK0948483T3/en active
- 1997-12-23 ES ES97953000T patent/ES2172033T3/en not_active Expired - Lifetime
- 1997-12-23 CA CA002275943A patent/CA2275943A1/en not_active Abandoned
- 1997-12-23 TR TR1999/01502T patent/TR199901502T2/en unknown
- 1997-12-23 AT AT97953000T patent/ATE214367T1/en not_active IP Right Cessation
- 1997-12-23 CZ CZ992335A patent/CZ233599A3/en unknown
- 1997-12-23 AU AU56694/98A patent/AU741921B2/en not_active Ceased
- 1997-12-23 DE DE69711081T patent/DE69711081T2/en not_active Expired - Fee Related
- 1997-12-23 KR KR1019997005966A patent/KR20000062391A/en not_active Application Discontinuation
- 1997-12-23 PT PT97953000T patent/PT948483E/en unknown
- 1997-12-23 EA EA199900608A patent/EA002114B1/en not_active IP Right Cessation
- 1997-12-23 HU HU0001747A patent/HUP0001747A3/en unknown
- 1997-12-23 ID IDW990618A patent/ID22922A/id unknown
- 1997-12-23 YU YU30299A patent/YU30299A/en unknown
- 1997-12-23 SK SK883-99A patent/SK88399A3/en unknown
- 1997-12-23 NZ NZ336042A patent/NZ336042A/en unknown
- 1997-12-23 IL IL13045397A patent/IL130453A0/en unknown
- 1997-12-23 BR BR9714498A patent/BR9714498A/en not_active IP Right Cessation
- 1997-12-23 PL PL97334345A patent/PL334345A1/en unknown
- 1997-12-23 JP JP52968698A patent/JP2001509147A/en not_active Ceased
- 1997-12-23 WO PCT/FR1997/002407 patent/WO1998029390A1/en not_active Application Discontinuation
- 1997-12-26 MA MA24915A patent/MA26460A1/en unknown
- 1997-12-26 TN TNTNSN97214A patent/TNSN97214A1/en unknown
- 1997-12-27 DZ DZ970239A patent/DZ2389A1/en active
- 1997-12-29 CO CO97075391A patent/CO4920252A1/en unknown
- 1997-12-30 AR ARP970106263A patent/AR008950A1/en unknown
- 1997-12-30 UY UY24832A patent/UY24832A1/en not_active Application Discontinuation
- 1997-12-30 ZA ZA9711734A patent/ZA9711734B/en unknown
-
1999
- 1999-06-29 NO NO993225A patent/NO993225L/en not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2736641B1 (en) | NOVEL FARNESYL TRANSFERASE INHIBITORS, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| FR2730491B1 (en) | NOVEL FARNESYL TRANSFERASE INHIBITORS, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| FR2736638B1 (en) | NOVEL FARNESYL TRANSFERASE INHIBITORS, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| FR2730492B1 (en) | NOVEL FARNESYL TRANSFERASE INHIBITORS, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| HUP9802448A3 (en) | Inhibitors of platelet aggregation, preparation and use thereof and pharmaceutical compositions | |
| IL133470A0 (en) | Inhibitors of farnesyl protein transferase and pharmaceutical compositions containing same | |
| FR2530625B1 (en) | INDOLE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| DZ2621A1 (en) | New prostaglandin agonists for their preparation and pharmaceutical compositions containing them. | |
| MA26443A1 (en) | ARALKYL- AND ARALKYLIDENE-LACTAMES AND -IMIDES HETEROCYCLIC, METHODS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| FI973039A (en) | New farnecyltransferase inhibitors, their preparation, and these containing pharmaceutical compositions | |
| HUP9702035A3 (en) | Inhibitors of leukocita-adhesion- and vla-4-antagonists and pharmaceutical compositions containing them | |
| HUP9702036A3 (en) | Inhibitors of leucocita-adhesion and wla-4-antagonists and pharmaceutical compositions containing them | |
| DZ2009A1 (en) | New taxoids, their preparation and the pharmaceutical compositions containing them. | |
| NZ305254A (en) | Farnesyl protein inhibitors and pharmaceutical compositions thereof | |
| FR04C0032I2 (en) | NEW QUINUCLIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| DZ2303A1 (en) | New indazole derivatives process for their preparation and pharmaceutical compositions containing them. | |
| HUP9900413A3 (en) | Use of coralyne derivatives, new coralyne derivatives and use thereof, pharmaceutical compositions containing these new coralyne derivatives | |
| DZ1958A1 (en) | Compounds inhibitors of the enzyme l-lpa pharmaceutical compositions composing them and methods for their preparation. | |
| DZ2149A1 (en) | New taxoids, their preparation and the pharmaceutical compositions containing them. | |
| NO985720D0 (en) | Aerosol drug formulations of formoterol | |
| DZ2600A1 (en) | Pharmaceutical combinations of amlodipine and estatin and process for their preparation. | |
| MC1915A1 (en) | Processes for the preparation of 2 ', 3'-dideoxynucleosides and pharmaceutical formulations containing them | |
| DZ2389A1 (en) | New farnesyl transferase inhibitors their preparation of the pharmaceutical compositions containing them and their use for the preparation of medicaments | |
| FR2721021B1 (en) | New farnesyl transferase inhibitors, their preparation and the pharmaceutical compositions containing them. | |
| FR2641276B1 (en) | BENZENE DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |